Jihyun (Luna) Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jihyun (Luna) Hwang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Joseph M. DeSimone
Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA
5 shared publications Gunilla B. Jacobson
Department of Radiology Stanford University School of Medicine Stanford California USA
3 shared publications- Netra Unni Rajesh
Department of Bioengineering, Stanford University, CA 94305, USA
3 shared publications - Abel Bermudez
Department of Radiology, School of Medicine, Stanford University, CA 94305, USA
2 shared publications Andy H. Hung
Department of Radiology Stanford University School of Medicine Stanford California USA
2 shared publications- Andy H. Hung
Department of Radiology, School of Medicine, Stanford University, CA 94305, USA
2 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (8) , 926
Vacuum-Assisted Microneedle Platforms for Dermal Interstitial Fluid Sampling
Background: Dermal interstitial fluid (ISF) contains both plasma-derived biomarkers and biomarkers unique to ISF, making it a promising biofluid for painless, scalable, and decentralized liquid biopsy and continuous health monitoring. However, efficient ISF collection remains challenging due to the small accessible fluid volume in the dermis, slow physiological turnover, and stratum corneum. Methods: This review reframes dermal ISF sampling as a pressure gradient engineering problem using Darcy’s law. We examine how vacuum-assisted microneedle platforms can effectively drive ISF through the dermal extracellular matrix in a minimally invasive manner. We compare the two architectures: micropore-based and hollow microneedle approaches. Results: In the micropore approach, a vacuum chamber is placed over the transient micropores left by withdrawn microneedles, supporting off-device, multi-omic downstream analyses of the collected ISF. The hollow microneedle approach retains the microneedles in the skin and applies vacuum through internal lumens, allowing integration of the vacuum source, microneedles, and biosensors into a single wearable platform for in situ biomarker detection. Comparative studies across these architectures identify the vacuum seal between the device and the skin as the major engineering bottleneck shared by both architectures. Conclusions: Vacuum-assisted microneedle platforms provide a practical route for generating pressure gradient-driven ISF transport while preserving minimally invasive skin access. Future development should prioritize device–skin vacuum seal robustness, reproducible ISF recovery across users and skin sites, integrated vacuum sources, scalable fabrication, and usability in clinical or at-home settings.
- 28 July 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (8) , 926
Open AccessVacuum-Assisted Microneedle Platforms for Dermal Interstitial Fluid Sampling
Background: Dermal interstitial fluid (ISF) contains both plasma-derived biomarkers and biomarkers unique to ISF, making it a promising biofluid for painless, scalable, and decentralized liquid biopsy and continuous health monitoring. However, efficient ISF collection remains challenging due to the small accessible fluid volume in the dermis, slow physiological turnover, and stratum corneum. Methods: This review reframes dermal ISF sampling as a pressure gradient engineering problem using Darcy’s law. We examine how vacuum-assisted microneedle platforms can effectively drive ISF through the dermal extracellular matrix in a minimally invasive manner. We compare the two architectures: micropore-based and hollow microneedle approaches. Results: In the micropore approach, a vacuum chamber is placed over the transient micropores left by withdrawn microneedles, supporting off-device, multi-omic downstream analyses of the collected ISF. The hollow microneedle approach retains the microneedles in the skin and applies vacuum through internal lumens, allowing integration of the vacuum source, microneedles, and biosensors into a single wearable platform for in situ biomarker detection. Comparative studies across these architectures identify the vacuum seal between the device and the skin as the major engineering bottleneck shared by both architectures. Conclusions: Vacuum-assisted microneedle platforms provide a practical route for generating pressure gradient-driven ISF transport while preserving minimally invasive skin access. Future development should prioritize device–skin vacuum seal robustness, reproducible ISF recovery across users and skin sites, integrated vacuum sources, scalable fabrication, and usability in clinical or at-home settings.
- Open Access
- 12 February 2026
- Published by Wiley in Advanced Materials Technologies
- Vol. 11 (10)
Tunable Applicator for Microneedle‐Based Medical Devices
This paper introduces a user‐friendly, one‐piece Tunable Applicator (TAPP) designed to improve the performance and usability of microneedle array patches (MAPs) and related microneedle‐based devices. Although MAPs hold significant potential for painless transdermal access for drug delivery, sensing, and fluid sampling purposes, their effectiveness is often limited by reliance on costly or bulky external applicators and complicated by variable user technique. TAPP addresses these challenges with a simple, intuitive, and low‐cost design based on a material‐agnostic mechanism of controlled fracture. This results in a highly adaptable and tunable architecture that allows precise control of force, ensuring reliable skin penetration and consistent engagement of the full microneedle array. Unlike conventional applicators, TAPP can also be manufactured as a built‐in component of the microneedle patch in a truly one‐step process, eliminating post‐fabrication assembly and simplifying manufacturing. Furthermore, the design is readily adaptable for integration with microneedle‐based devices used in sensing and diagnostics, such as health monitoring and interstitial fluid sampling, expanding its utility beyond drug delivery. By combining mechanical simplicity with reliable and repeatable performance, TAPP has the potential to accelerate translation of microneedle‐based technologies from laboratory development to practical, widespread clinical and at‐home use.
- 12 February 2026
- Published by Wiley in Advanced Materials Technologies
- Vol. 11 (10)
Open AccessTunable Applicator for Microneedle‐Based Medical Devices
This paper introduces a user‐friendly, one‐piece Tunable Applicator (TAPP) designed to improve the performance and usability of microneedle array patches (MAPs) and related microneedle‐based devices. Although MAPs hold significant potential for painless transdermal access for drug delivery, sensing, and fluid sampling purposes, their effectiveness is often limited by reliance on costly or bulky external applicators and complicated by variable user technique. TAPP addresses these challenges with a simple, intuitive, and low‐cost design based on a material‐agnostic mechanism of controlled fracture. This results in a highly adaptable and tunable architecture that allows precise control of force, ensuring reliable skin penetration and consistent engagement of the full microneedle array. Unlike conventional applicators, TAPP can also be manufactured as a built‐in component of the microneedle patch in a truly one‐step process, eliminating post‐fabrication assembly and simplifying manufacturing. Furthermore, the design is readily adaptable for integration with microneedle‐based devices used in sensing and diagnostics, such as health monitoring and interstitial fluid sampling, expanding its utility beyond drug delivery. By combining mechanical simplicity with reliable and repeatable performance, TAPP has the potential to accelerate translation of microneedle‐based technologies from laboratory development to practical, widespread clinical and at‐home use.
- Open Access
- 26 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (39) , eadx5492
A microneedle device for rapid dermal interstitial fluid sampling
Dermal interstitial fluid (ISF) offers a promising alternative to invasive blood tests and opportunities for skin diagnostics. Progress in both the understanding and adoption of ISF tests is hindered by sampling challenges, including lengthy collection times, non-negligible failure rates, variable collection volumes, and inconsistent bioanalyte levels. The causes of many of these issues are not well understood. We demonstrate a microneedle device that is several times faster than state of the art, collecting an average of 15.5 mg of ISF in 5 minutes in humans with near-zero failure rate. This improvement was achieved by designing the spatial pressure gradient driving ISF flow. The influence of penetration depth, collection time, pressure, and age on ISF collection was elucidated, with Darcy’s law explaining multiple observations. A data-driven acceptance criterion of <1% blood contamination for ISF is proposed. The device and findings presented will empower researchers to better conduct robust studies in the development of ISF diagnostics.
- 26 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (39) , eadx5492
Open AccessA microneedle device for rapid dermal interstitial fluid sampling
Dermal interstitial fluid (ISF) offers a promising alternative to invasive blood tests and opportunities for skin diagnostics. Progress in both the understanding and adoption of ISF tests is hindered by sampling challenges, including lengthy collection times, non-negligible failure rates, variable collection volumes, and inconsistent bioanalyte levels. The causes of many of these issues are not well understood. We demonstrate a microneedle device that is several times faster than state of the art, collecting an average of 15.5 mg of ISF in 5 minutes in humans with near-zero failure rate. This improvement was achieved by designing the spatial pressure gradient driving ISF flow. The influence of penetration depth, collection time, pressure, and age on ISF collection was elucidated, with Darcy’s law explaining multiple observations. A data-driven acceptance criterion of <1% blood contamination for ISF is proposed. The device and findings presented will empower researchers to better conduct robust studies in the development of ISF diagnostics.
- Open Access
A Microneedle Device for Rapid Dermal Interstitial Fluid Sampling
Dermal interstitial fluid (ISF) offers a promising alternative to invasive blood tests and opportunities for novel skin diagnostics. Progress in both the understanding and adoption of ISF tests is hindered by sampling challenges, including lengthy collection times, non-negligible failure rates, variable collection volumes, and inconsistent bioanalyte levels. The causes of many of these issues are not well understood. We demonstrate a microneedle device that is several times faster than state-of-the-art, collecting an average of 15.5 mg of ISF in 5 minutes in humans with near-zero failure rate. This improvement was achieved by designing the spatial pressure gradient driving ISF flow. The influence of penetration depth, collection time, pressure, and age on ISF collection was elucidated, with Darcy’s law explaining multiple observations. A data-driven acceptance criterion of <1% blood contamination for ISF is proposed. The device and findings presented will empower researchers to better conduct robust studies in the development of ISF diagnostics.
Open AccessA Microneedle Device for Rapid Dermal Interstitial Fluid Sampling
Dermal interstitial fluid (ISF) offers a promising alternative to invasive blood tests and opportunities for novel skin diagnostics. Progress in both the understanding and adoption of ISF tests is hindered by sampling challenges, including lengthy collection times, non-negligible failure rates, variable collection volumes, and inconsistent bioanalyte levels. The causes of many of these issues are not well understood. We demonstrate a microneedle device that is several times faster than state-of-the-art, collecting an average of 15.5 mg of ISF in 5 minutes in humans with near-zero failure rate. This improvement was achieved by designing the spatial pressure gradient driving ISF flow. The influence of penetration depth, collection time, pressure, and age on ISF collection was elucidated, with Darcy’s law explaining multiple observations. A data-driven acceptance criterion of <1% blood contamination for ISF is proposed. The device and findings presented will empower researchers to better conduct robust studies in the development of ISF diagnostics.
- Open Access
- 2 September 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (44) , e2404606
3D‐Printed Latticed Microneedle Array Patches for Tunable and Versatile Intradermal Delivery
Using high‐resolution 3D printing, a novel class of microneedle array patches (MAPs) is introduced, called latticed MAPs (L‐MAPs). Unlike most MAPs which are composed of either solid structures or hollow needles, L‐MAPs incorporate tapered struts that form hollow cells capable of trapping liquid droplets. The lattice structures can also be coated with traditional viscous coating formulations, enabling both liquid‐ and solid‐state cargo delivery, on a single patch. Here, a library of 43 L‐MAP designs is generated and in‐silico modeling is used to down‐select optimal geometries for further characterization. Compared to traditionally molded and solid‐coated MAPs, L‐MAPs can load more cargo with fewer needles per patch, enhancing cargo loading and drug delivery capabilities. Further, L‐MAP cargo release kinetics into the skin can be tuned based on formulation and needle geometry. In this work, the utility of L‐MAPs as a platform is demonstrated for the delivery of small molecules, mRNA lipid nanoparticles, and solid‐state ovalbumin protein. In addition, the production of programmable L‐MAPs is demonstrated with tunable cargo release profiles, enabled by combining needle geometries on a single patch.
- 2 September 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (44) , e2404606
Open Access3D‐Printed Latticed Microneedle Array Patches for Tunable and Versatile Intradermal Delivery
Using high‐resolution 3D printing, a novel class of microneedle array patches (MAPs) is introduced, called latticed MAPs (L‐MAPs). Unlike most MAPs which are composed of either solid structures or hollow needles, L‐MAPs incorporate tapered struts that form hollow cells capable of trapping liquid droplets. The lattice structures can also be coated with traditional viscous coating formulations, enabling both liquid‐ and solid‐state cargo delivery, on a single patch. Here, a library of 43 L‐MAP designs is generated and in‐silico modeling is used to down‐select optimal geometries for further characterization. Compared to traditionally molded and solid‐coated MAPs, L‐MAPs can load more cargo with fewer needles per patch, enhancing cargo loading and drug delivery capabilities. Further, L‐MAP cargo release kinetics into the skin can be tuned based on formulation and needle geometry. In this work, the utility of L‐MAPs as a platform is demonstrated for the delivery of small molecules, mRNA lipid nanoparticles, and solid‐state ovalbumin protein. In addition, the production of programmable L‐MAPs is demonstrated with tunable cargo release profiles, enabled by combining needle geometries on a single patch.